Phosplatin Therapeutics
Permanently closed
Advertisement
1350 Avenue of the Americas Ste 2305
New York, NY 10019
Phosplatin Therapeutics, based in New York, is dedicated to addressing unmet needs in oncology immunotherapy through the development of innovative small molecule anti-cancer agents.
Their lead agent, PT-112, is a cutting-edge immunogenic cell death inducer, setting the standard as a best-in-class treatment option for cancer patients.
Generated from their website's infomation
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.
Advertisement
